Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study
BackgroundApproximately 62% of patients with breast cancer with a pathogenic variant (BRCA1 or BRCA2) undergo primary breast-conserving therapy. ObjectiveThe study aims to develop a personalized risk management decision support tool for carriers of a pathogenic va...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2022-12-01
|
Series: | JMIR Formative Research |
Online Access: | https://formative.jmir.org/2022/12/e37144 |